
AstraZeneca PLC (AZN) Market Capitalization Overview
Market Cap: $292.13B as of Feb 2, 2026
$292.13B
$275.72B (48.56%)past month
As of Feb 2, 2026, AstraZeneca PLC (AZN) has a market capitalization of $292.13B. Over the past 30 days, its market cap has decreased by -48.56%, while in the last 12 months, it has decreased by -48.76%.
Market capitalization represents the total value of AstraZeneca PLC as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
AstraZeneca PLC (AZN) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of AstraZeneca PLC (AZN) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of AstraZeneca PLC as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
AstraZeneca PLC (AZN) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of AstraZeneca PLC (AZN) helps investors assess the company's size and compare it with competitors for better investment decisions.
AstraZeneca PLC (AZN) Market Cap & Key Trends
See AstraZeneca PLC’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in AstraZeneca PLC (AZN)
Order type
Buy in
Order amount
Est. shares
0 shares
AstraZeneca PLC (AZN) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $561.33B | +10.77% |
| Nov 3, 2025 | $506.75B | -3.13% |
| Oct 1, 2025 | $523.12B | +5.20% |
| Sep 2, 2025 | $497.26B | +8.41% |
| Aug 1, 2025 | $458.69B | +3.49% |
| Jul 1, 2025 | $443.25B | -0.65% |
| Jun 2, 2025 | $446.16B | +2.02% |
| May 1, 2025 | $437.34B | -2.88% |
| Apr 1, 2025 | $450.30B | -4.60% |
| Mar 3, 2025 | $471.99B | +8.93% |
| Feb 3, 2025 | $433.29B | +6.06% |
| Jan 2, 2025 | $408.55B | -1.73% |
AstraZeneca PLC (AZN) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $292.13B | -48.76% |
| 2025 | $570.08B | +40.31% |
| 2024 | $406.31B | -2.69% |
| 2023 | $417.56B | -0.64% |
| 2022 | $420.24B | +16.42% |
| 2021 | $360.96B | — |
FAQs About AstraZeneca PLC (AZN) Market Cap
As of Feb 2, 2026, the market capitalization of AstraZeneca PLC (AZN) is $292.13B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, AstraZeneca PLC’s market capitalization has decreased by -48.56%, changing from $567.85B to $292.13B as of Feb 2, 2026.
In the last 3 months, AstraZeneca PLC’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, AstraZeneca PLC’s market capitalization increased from $406.31B in January to $570.08B in December, reflecting a 40.31% change.
In the past five years, AstraZeneca PLC (AZN) has had a compound annual growth rate (CAGR) of 9.57% in market capitalization. This means its market cap has grown at an average rate of 9.57% per year.